Mark Dowling, based in Cambridge, MA, US, is currently a Head external Innovation - Immunology at Sanofi Genzyme. Mark Dowling brings experience from previous roles at Kaleido Biosciences and Novartis Institutes for BioMedical Research (NIBR). Mark Dowling holds a 2000 - 2003 Ph.D in GPCR Pharmacology @ University of Leicester. With a robust skill set that includes Biomarkers, Pharmacology, Fibrosis, Pharmaceutical Industry, Assay Development and more. He holds a Ph.D, GPCR Pharmacology from the University of Leicester.